Biopharmaceutical Manufacturing Operations (Downstream Processing)
Develops, characterizes, scales, and transfers downstream purification processes (chromatography, filtration, viral clearance, harvest/clarification) for recombinant protein and biologic drug substances. Distinct from Upstream Processing (cell culture/fermentation) and Analytical Development (assay development); this focus owns the recovery and purification train from cell harvest through bulk drug substance, including yield, purity, viral safety, and CMC control strategy.
5 leveled profiles. Pick a level to see the full profile.
Individual contributor
Develops, characterizes, scales, and transfers downstream purification processes (chromatography, filtration, viral clearance, harvest/clarification) for recombinant protein and biologic drug substances. Distinct from Upstream Processing (cell culture/fermentation) and Analytical Development (assay development); this focus owns the recovery and purification train from cell harvest through bulk drug substance, including yield, purity, viral safety, and CMC control strategy.
Develops, characterizes, scales, and transfers downstream purification processes (chromatography, filtration, viral clearance, harvest/clarification) for recombinant protein and biologic drug substances. Distinct from Upstream Processing (cell culture/fermentation) and Analytical Development (assay development); this focus owns the recovery and purification train from cell harvest through bulk drug substance, including yield, purity, viral safety, and CMC control strategy.
Develops, characterizes, scales, and transfers downstream purification processes (chromatography, filtration, viral clearance, harvest/clarification) for recombinant protein and biologic drug substances. Distinct from Upstream Processing (cell culture/fermentation) and Analytical Development (assay development); this focus owns the recovery and purification train from cell harvest through bulk drug substance, including yield, purity, viral safety, and CMC control strategy.
Develops, characterizes, scales, and transfers downstream purification processes (chromatography, filtration, viral clearance, harvest/clarification) for recombinant protein and biologic drug substances. Distinct from Upstream Processing (cell culture/fermentation) and Analytical Development (assay development); this focus owns the recovery and purification train from cell harvest through bulk drug substance, including yield, purity, viral safety, and CMC control strategy.
Develops, characterizes, scales, and transfers downstream purification processes (chromatography, filtration, viral clearance, harvest/clarification) for recombinant protein and biologic drug substances. Distinct from Upstream Processing (cell culture/fermentation) and Analytical Development (assay development); this focus owns the recovery and purification train from cell harvest through bulk drug substance, including yield, purity, viral safety, and CMC control strategy.